Consumption of processed and sugary foods is a significant contributor to diabetes prevalence. The country's rapid expansion and modernization have led to increased intake of calorie-rich, unhealthy foods, leading to higher rates of type 2 diabetes, obesity, and cardiovascular issues. Consequently, there is a growing demand for health management solutions.
Another key factor is the increasing adoption of digital health solutions, including wearable devices, mobile applications, and telemedicine. These technologies offer convenient ways for patients to monitor their blood sugar levels, track their diet and exercise, and communicate with healthcare providers remotely, thus enhancing overall diabetes management.
Saudi Arabia Digital Diabetes Management Market Report Highlights
- Based on product, the continuous glucose monitoring systems segment accounted for the largest revenue share of 38.6% in 2023 due to its ability to provide accurate and real-time blood glucose readings, facilitating timely management of diabetes
- Based on product, the smart insulin pens segment is expected to grow at the fastest CAGR of 9.8% over the forecast period. Their built-in memory capabilities allow tracking and analyzing insulin doses over time, enabling better treatment adjustments. Features like dose reminders and connectivity to mobile apps enhance user engagement and adherence to insulin therapy regimens.
- Based on type, the wearable devices segment accounted for the largest revenue share of 57.0% in 2023 and is projected to grow at the fastest CAGR of 9.0% over the forecast period. They promote active self-management by empowering individuals with instant feedback and alerts, facilitating timely interventions to maintain optimal health
- Based on end-use, the home settings segment has captured the largest market share of 64.3% in 2023 and is expected to grow at the fastest CAGR of 6.7% over the forecast period. They offer a familiar and comfortable environment for individuals to manage their diabetes effectively without the constraints of a clinical setting. They enable personalized care tailored to the individual's needs, promoting autonomy and self-management.
Table of Contents
Companies Mentioned
- Salehiya Medical W/H (SA)
- Aljeel Medical (SA)
- Alhammad Medical (SA)
- Johnson & Johnson
- Medtronic
- Philipps Healthcare
- Dexcom
- Ascensia Diabetes Care
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 195 |
Published | May 2024 |
Forecast Period | 2023 - 2030 |
Estimated Market Value ( USD | $ 116.4 Million |
Forecasted Market Value ( USD | $ 208.3 Million |
Compound Annual Growth Rate | 8.9% |
Regions Covered | Saudi Arabia |
No. of Companies Mentioned | 8 |